RedHill Biopharma Announces Publication of RHB-102 Gastroenteritis Phase 3 Study Results in JAMA
12 nov. 2019 07h00 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 12, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty...
Equillium to Present New Data and Insights on the CD6-ALCAM Pathway in Lupus Nephritis at ACR 2019
06 nov. 2019 08h05 HE
|
Equillium
LA JOLLA, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal of Neurodevelopmental Disorders
06 août 2019 08h00 HE
|
Zynerba Pharmaceuticals, Inc.
DEVON, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
06 août 2019 08h00 HE
|
GeneDx
GAITHERSBURG, Md., Aug. 06, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., and a recognized leader in genetic and genomic testing, announced the results...
WERELDHAVE N.V.: Wereldhave proposes the appointment of Françoise Dechesne as new member to its Supervisory Board
13 mars 2019 06h32 HE
|
Wereldhave N.V.
Wereldhave N.V. announces today that it will propose to the 2019 Annual General Meeting of Shareholders on 26 April 2019 that Mrs. Françoise Dechesne be appointed as member of the Supervisory Board of...
New Research Shows How Diagnostic Testing Can Advance the Identification and Treatment of Harmful Drug-Drug Interactions
05 déc. 2018 09h55 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers,...
New Research Reveals the Prevalence of Drug-Drug Interactions and the Economic Impact on the Healthcare System
05 nov. 2018 14h00 HE
|
Aegis Sciences Corporation
Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective information leads to a reduction of interactions...
NUGL Expands Operations and Footprint
30 oct. 2018 08h30 HE
|
NUGL Inc.
LOS ANGELES, Oct. 30, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry's new standard of technology, today reports it has expanded internal...
Lithographic Printing Chemicals Market to hit $17.5bn by 2025: Global Market Insights, Inc.
08 oct. 2018 02h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Lithographic Printing Chemicals Market is set to exceed USD 17 billion by 2025; according to a new research report by Global Market...
Registration for the 2017 University Program is Now Open at The International Institute for Genocide and Human Rights Studies (IIGHRS)
06 mars 2017 13h09 HE
|
The International Institute for Genocide and Human Rights Studies (A Division of the Zoryan Institute)
TORONTO, ON--(Marketwired - March 06, 2017) - The IIGHRS is pleased to announce that registration for the summer 2017 Genocide and Human Rights University Program (GHRUP) is now open. The Institute...